ArticleItalian journal of pediatrics2017

The impact of the recent AAP changes in palivizumab authorization on RSV-induced bronchiolitis severity and incidence.

Antonino Capizzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.